ArticleJournal of clinical pharmacology2026

A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ-63733657) in Healthy Chinese Adults.

Fangfang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.